Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IMC-001 |
Synonyms | |
Therapy Description |
IMC-001 is an anti-PD-L1 (CD274) antibody that stimulates the anti-tumor response (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMC-001 | IMC001|IMC 001|STI 3031 | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 122 | IMC-001 is an anti-PD-L1 (CD274) antibody that stimulates the anti-tumor response (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05393713 | Phase I | IMC-001 | Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for the Treatment of In-Transit Melanoma, The Sofusa-2 Study | Active, not recruiting | USA | 0 |